LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3019% above fair value
$90.73−1.34 (-1.46%)
Close on Nov 20, 2026Market cap $5.00BP/E 26.8Yield –
LivaNova operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
LivaNova's operating income for the twelve months ending Jun 30, 2026 was $187.55M, up 6.9% year over year. For fiscal 2025 it was $199.39M, up 54.5% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $199.39M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $199.39M | +54.5% |
| FY2024 | Dec 31, 2024 | $129.05M | – |
| FY2023 | Dec 31, 2023 | -$68.50M | – |
| FY2022 | Dec 31, 2022 | -$76.75M | – |
| FY2021 | Dec 31, 2021 | -$784.00K | – |
| FY2020 | Dec 31, 2020 | -$273.90M | – |
| FY2019 | Dec 31, 2019 | -$171.55M | – |
| FY2018 | Dec 31, 2018 | -$248.07M | -357.1% |
| FY2017 | Dec 31, 2017 | $96.49M | +8.8% |
| FY2015 | Apr 24, 2015 | $88.65M | +10.8% |
| FY2014 | Apr 25, 2014 | $80.01M | +2.1% |
| FY2013 | Apr 26, 2013 | $78.35M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $49.48M | -8.7% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $41.47M | -14.7% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $42.58M | +15.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $54.01M | +51.6% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $54.18M | +34.9% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $48.62M | +199.3% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $37.02M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $35.62M | +699.0% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $40.17M | +131.2% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $16.25M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$87.99M | -730.3% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $4.46M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $17.38M | -45.3% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$2.34M | -124.6% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $13.96M | -43.6% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$131.97M | -903.6% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $31.76M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $9.51M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $24.75M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $16.42M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$36.26M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$5.70M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$249.02M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$7.55M | -129.3% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$16.74M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$581.00K | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$143.98M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $25.76M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$29.88M | -238.3% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$20.78M | -265.8% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$276.45M | -1559.4% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$5.76M | -119.2% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $21.61M | -22.2% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $12.53M | -36.5% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $18.94M | +13.3% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $30.02M | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $27.78M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $19.75M | – |
| Q4 FY2015CQ1 2015 | Apr 24, 2015 | $16.72M | – |
See a number that looks wrong?